Cell Therapeutics seeking EMA approval of Pixuvri

Cell Therapeutics Inc. (NASDAQ:CTIC; Milan:CTIC) submitted an MAA to the European Medicines Agency for Pixuvri pixantrone as monotherapy to treat adult patients with relapsed or refractory aggressive ...